Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates
Maurizio Muratore, Eugenio Quarta, Antonella Grimaldi, Fabio Calcagnile, Laura Quarta Department of Rheumatology, Hospital Galateo, San Cesario di Lecce, Italy Abstract: Bisphosphonates have a long history in the treatment of osteoporosis and bone-related disease. This review focuses on the use of a...
Saved in:
Main Authors: | Muratore M (Author), Quarta E (Author), Grimaldi A (Author), Calcagnile F (Author), Quarta L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of cutaneous discomfort in patients with scleroderma: a clinical trial
by: M. Muratore, et al.
Published: (2013) -
Osteoporosis and diabetes
by: M. Barbagallo, et al.
Published: (2011) -
Osteonecrosis of the jaw in a patient under treatment of osteoporosis with oral bisphosphonate
by: Marília A. Figueiredo, et al.
Published: (2021) -
Changes in the utilization of osteoporosis drugs after the 2010 FDA bisphosphonate drug safety communication
by: Bander Balkhi, et al.
Published: (2018) -
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
by: Michael Pazianas, et al.
Published: (2010)